These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35134155)

  • 1. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
    Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
    Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute oesophageal safety and long-term follow-up of AI-guided high-power short-duration with 50 W for atrial fibrillation ablation.
    Müller J; Nentwich K; Berkovitz A; Ene E; Sonne K; Zhuravlev V; Chakarov I; Barth S; Waechter C; Behnes M; Halbfass P; Deneke T
    Europace; 2023 Apr; 25(4):1379-1391. PubMed ID: 36881791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher power short duration vs. lower power longer duration posterior wall ablation for atrial fibrillation and oesophageal injury outcomes: a prospective multi-centre randomized controlled study (Hi-Lo HEAT trial).
    Chieng D; Segan L; Sugumar H; Al-Kaisey A; Hawson J; Moore BM; Nam MCY; Voskoboinik A; Prabhu S; Ling LH; Ng JF; Brown G; Lee G; Morton J; Debinski H; Kalman JM; Kistler PM
    Europace; 2023 Feb; 25(2):417-424. PubMed ID: 36305561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
    Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
    J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal safety in CLOSE-guided 50 W high-power-short-duration pulmonary vein isolation: The PREHEAT-PVI-registry.
    Francke A; Naumann G; Weidauer MC; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2022 Nov; 33(11):2276-2284. PubMed ID: 35979645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
    Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vein isolation using pulsed field ablation vs. high-power short-duration radiofrequency ablation in paroxysmal atrial fibrillation: efficacy, safety, and long-term follow-up (PRIORI study).
    Reinsch N; Füting A; Hartl S; Höwel D; Rausch E; Lin Y; Kasparian K; Neven K
    Europace; 2024 Jul; 26(7):. PubMed ID: 38996227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of two 50 W high power short duration approaches-Temperature- versus ablation index-guided radiofrequency ablation for atrial fibrillation.
    Guckel D; Bergau L; Braun M; El Hamriti M; Mörsdorf M; Fink T; Sciacca V; Khalaph M; Imnadze G; Sommer P; Sohns C
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2517-2527. PubMed ID: 36104929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of asymptomatic oesophageal lesions after atrial fibrillation ablation using an oesophageal temperature probe with insulated thermocouples: a comparative controlled study.
    Halbfass P; Müller P; Nentwich K; Krug J; Roos M; Hamm K; Barth S; Szöllösi A; Mügge A; Schieffer B; Deneke T
    Europace; 2017 Mar; 19(3):385-391. PubMed ID: 27540039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kottmaier M; Popa M; Bourier F; Reents T; Cifuentes J; Semmler V; Telishevska M; Otgonbayar U; Koch-Büttner K; Lennerz C; Bartkowiak M; Kornmayer M; Rousseva E; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I
    Europace; 2020 Mar; 22(3):388-393. PubMed ID: 31872249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of acute thermal esophageal injury after atrial fibrillation ablation guided by prespecified ablation index.
    Halbfass P; Berkovitz A; Pavlov B; Sonne K; Nentwich K; Ene E; Hoerning F; Barth S; Zacher M; Deneke T
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2256-2261. PubMed ID: 31559655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high-power short-duration pulmonary vein isolation and substrate modification using the CLOSE protocol.
    Francke A; Taha NS; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2021 Sep; 32(9):2408-2417. PubMed ID: 34252990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of very high-power short-duration radiofrequency ablation for pulmonary vein isolation: a two-centre report with emphasis on silent oesophageal injury.
    Halbfass P; Wielandts JY; Knecht S; Le Polain de Waroux JB; Tavernier R; De Wilde V; Sonne K; Nentwich K; Ene E; Berkovitz A; Mueller J; Lehmkuhl L; Reichart A; Lüsebrink U; Duytschaever M; Deneke T
    Europace; 2022 Mar; 24(3):400-405. PubMed ID: 34757432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiofrequency ablation of atrial fibrillation-50 W or 90 W?
    Mueller J; Nentwich K; Ene E; Berkovitz A; Sonne K; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Halbfass P; Deneke T
    J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2504-2513. PubMed ID: 36124396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of atrial fibrillation using ablation index-guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II).
    Chen S; Schmidt B; Seeger A; Bordignon S; Tohoku S; Willems F; Urbanek L; Throm C; Konstantinou A; Plank K; Hilbert M; Zanchi S; Bianchini L; Bologna F; Tsianakas N; Kreuzer C; Chun KRJ
    Heart Rhythm; 2020 Nov; 17(11):1833-1840. PubMed ID: 32470628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of ablation-induced esophageal lesions and gastroparesis in patients undergoing ablation index guided high power short duration atrial fibrillation ablation.
    List S; Meinhardt C; Mueller J; Deneke T; Barth S; Waechter C; Luesebrink U; Elsaesser A; Arlt A; Halbfass P
    J Cardiovasc Electrophysiol; 2023 Jan; 34(1):82-89. PubMed ID: 36321661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between High-Power Short-Duration and Conventional Ablation Strategy in Atrial Fibrillation: An Updated Meta-Analysis.
    Li M; Ma Y; Lin Q; Huang Y; Liu Y; Tu T; Liu Q
    Cardiovasc Ther; 2022; 2022():1065077. PubMed ID: 35975140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation of atrial fibrillation using ablation index-guided high-power technique: Frankfurt AI high-power 15-month follow-up.
    Chen S; Schmidt B; Bordignon S; Tohoku S; Urban VC; Schulte-Hahn B; Chun KRJ
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):616-624. PubMed ID: 33484215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophageal safety in voltage-guided atrial fibrillation ablation using ablation index or contact force only: a prospective comparison.
    Schade A; Costello-Boerrigter L; Deneke T; Steinborn F; Chapran M; Vathie K; Milisavljevic N; Franz M; Surber R; Assani M; Hamo H; Khshfeh M; Lauten A; Mattea V
    Europace; 2022 Dec; 24(12):1909-1916. PubMed ID: 35851917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Power Short-Duration Lesion Index-Guided Posterior Wall Isolation beyond Pulmonary Vein Isolation for Persistent Atrial Fibrillation.
    Conti S; Sabatino F; Fortunato F; Ferrara G; Cascino A; Sgarito G
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.